The Journal of Allergy and Clinical Immunology: In Practice
Original ArticleEarly Exposure to Cow's Milk Protein Is Associated with a Reduced Risk of Cow's Milk Allergic Outcomes
Section snippets
Methods
The HealthNuts study methods have been described in detail previously.19 Between 2007 and 2011, 5,276 infants were recruited from council-run immunization sessions and offered skin prick testing (SPT) to 4 common food allergens. All infants underwent SPT to egg white, peanut, and sesame; the first half of the cohort received an additional SPT to shrimp, whereas the second half received SPT to cow's milk. Initially, cow's milk SPT was not conducted because of failure to gain ethics committee
Participation and cow's milk allergy outcomes
A total of 5,276 twelve-month-old infants participated in the HealthNuts study (74% participation). Participation in cow's milk SPT including determination of cow's milk allergy status and proportion of the sample with data on early exposure to cow's milk protein is presented in Figure 1, A. Cow's milk SPT was only conducted on the second half of the cohort and 2.2% (95% CI 1.7-2.8%, n = 60/2,715) were sensitized at the population level. Responses to parent-reported reactions to cow's milk were
Discussion
In this population-based cohort, early exposure to cow's milk protein in the first 3 months of life was associated with a reduced risk of all cow's milk atopic outcomes considered, including sensitization, parent-reported reactions, and presumed allergy at age 1 year, even after adjusting for confounding variables including family history of allergy.
The strengths of this study are the large sample size, high participation fraction, and good internal and external validity.19 Sensitization to
Acknowledgments
The HealthNuts study thanks the children and parents who participated in the HealthNuts study as well as the staff of Melbourne's Local Government Areas for providing access to community immunization clinics. We thank ALK-Abello SA, Madrid, Spain, for supplying the skin prick testing reagents; and the HealthNuts safety committee comprising Associate Professor Noel Cranswick (Australian Paediatric Pharmacology Research Unit, Murdoch Childrens Research Institute, Parkville, Victoria, Australia),
References (31)
- et al.
Randomized placebo-controlled trial of hen's egg consumption for primary prevention in infants
J Allergy Clin Immunol
(2017) - et al.
Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): a randomised, double-blind, placebo-controlled trial
Lancet
(2017) - et al.
Early regular egg exposure in infants with eczema: A randomized controlled trial
J Allergy Clin Immunol
(2013) - et al.
Randomized controlled trial of early regular egg intake to prevent egg allergy
J Allergy Clin Immunol
(2017) - et al.
A randomized trial of egg introduction from 4 months of age in infants at risk for egg allergy
J Allergy Clin Immunol
(2017) - et al.
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy
J Allergy Clin Immunol
(2010) - et al.
The association of the delayed introduction of cow’s milk with IgE-mediated cow’s milk allergies
J Allergy Clin Immunol Pract
(2016) - et al.
Skin test reactivity in infancy
J Allergy Clin Immunol
(1985) - et al.
Skin test reactivity to histamine from infancy to old age
J Allergy Clin Immunol
(1987) - et al.
Can early introduction of egg prevent egg allergy in infants? A population-based study
J Allergy Clin Immunol
(2010)
Beta-lactoglobulin secretion in human milk varies widely after cow's milk ingestion in mothers of infants with cow's milk allergy
J Allergy Clin Immunol
Prevention of food allergy
J Allergy Clin Immunol
Randomized trial of peanut consumption in infants at risk for peanut allergy
N Engl J Med
Timing of allergenic food introduction to the infant diet and risk of allergic or autoimmune disease: a systematic review and meta-analysis
JAMA
The natural history of milk allergy in an observational cohort
J Allergy Clin Immunol
Cited by (49)
Accounting for the health risk of probiotics
2024, HeliyonPrevalence and risk factors of cow's milk sensitization and allergy in southeast Australia
2023, Journal of Allergy and Clinical Immunology: In PracticeFood allergy and infant feeding practices: Are they related?
2023, Annals of Allergy, Asthma and ImmunologyEarly Introduction of Allergenic Foods in Infants and Children
2023, Journal for Nurse PractitionersParental food selection questionnaire - Infant version
2023, Appetite
The HealthNuts study was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia, Ilhan Food Allergy Foundation, AnaphylaxiStop, the Charles and Sylvia Viertel Medical Research Foundation, the Victorian Government’s Operational Infrastructure Support Program, and the NHMRC Centre for Food and Allergy Research. S. C. Dharmage, A. J. Lowe, and K. J. Allen hold NHMRC awards.
Conflict of interest: K. J. Allen personally received consultancy fees from ThermoFisher, and is on the Before Brands Scientific Advisory Board. V. L. McWilliam reports personal fees from Speaker Honorarium for Aspen Global, Abbott Australasia, and Nestle Health Sciences and personal fees from Advisory Panel Consultancy for Nutricia, outside the submitted work. M. L. K. Tang is on the Nestle Medical Advisory Board Oceania and the Danone Nutricia Global Scientific Advisory Board; received consultancy fees from Deerfield Consulting, GLG consulting, and Bayer; is employed by and has stock/employee stock options from ProTA Therapeutics; received payment for lectures from Danone Nutricia, Abbott Australia, and Nestle Health Sciences; receives royalties from Wilkinson Publishing; and has a patent through Murdoch Children's Research Institute. Her institution received grants from the National Health and Medical Research Council Australia and patents from ProTA Therapeutics for other works. A. J. Lowe reports grants from the National Health and Medical Research Council during the conduct of the study. The rest of the authors declare that they have no relevant conflicts of interest.